PPARG and fatty liver disease: The effects of PPARγ agonism on the liver remain under debate, with some studies showing that it promotes hepatic steatosis through upregulation of the genes involved in lipid uptake and storage and other studies showing that it prevents hepatic steatosis and fibrosis46.